Home Cart Sign in  
Chemical Structure| 302-79-4 Chemical Structure| 302-79-4

Structure of Retinoic acid
CAS No.: 302-79-4

Chemical Structure| 302-79-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Retinoic acid (Vitamin A acid) acts as an RAR nuclear receptor agonist and is used as an adjunct in cell therapy.

Synonyms: Vitamin A acid; all-trans-Retinoic acid; ATRA

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Sha-sha, LIU ; YAN, SHI ;

Abstract: Objective: To study the effects of all-trans-retinoic acid (ATRA) on proliferation, migration and cycle of human gastric cancer MGC-803 cells. Methods: The proliferation activity of gastric cancer MGC-803 cells treated with different concentrations of ATRA was detected by CCK-8 assay. The morphological changes of MGC-803 cells in each group were observed under inverted microscope. The migration ability of cells in each group was detected by scratch test. Flow cytometry was used to detect the change of MGC-803 cell cycle. Results: CCK-8 results showed that ATRA could significantly inhibit the proliferation of MGC-803 cells, and the inhibition rate of cell proliferation increased gradually with the increasing of ATRA concentrations and action time, in a dose-time dependent manner(P<0.05). Under inverted microscope, the morphology of MGC-803 cells changed and the number of viable cells decreased significantly after ATRA treatment. The results of scratch assay showed that ATRA could significantly inhibit the migration of gastric cancer MGC-803 cells, and the repair rate of scratch area decreased significantly with the increasing of ATRA concentration(P<0.05). Flow cytometry showed that the proportion of G0/G1 phase cells increased significantly after ATRA treatment, and the proportion of S phase cells decreased (P<0.05). And there was no significant change in G2/M phase cell proportion (P>0.05). Conclusion: ATRA could significantly inhibit the proliferation and migration of human gastric cancer MGC-803 cells, suggesting that the mechanism might be to block the cells in G0/G1 phase by affecting the cell cycle process.

Keywords: gastric cancer ; ATRA ; proliferation ; migration ; cell cycle

Purchased from AmBeed:

Alternative Products

Product Details of Retinoic acid

CAS No. :302-79-4
Formula : C20H28O2
M.W : 300.44
SMILES Code : CC1(C(=C(CCC1)C)C=CC(=CC=CC(=CC(O)=O)C)C)C
Synonyms :
Vitamin A acid; all-trans-Retinoic acid; ATRA
MDL No. :MFCD00001551

Safety of Retinoic acid

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H315-H360-H410
Precautionary Statements:P201-P202-P264-P270-P273-P280-P301+P312+P330-P302+P352-P308+P313-P332+P313-P391-P405-P501
Class:9
UN#:3077
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HepG2 5 µM and 10 µM 48 hours Enhanced the cytotoxicity of sorafenib Cancer Sci. 2015 May;106(5):567-75
Human fetal lung capillary endothelial precursor cells 0.01, 0.1, 1 µM 24 hours To evaluate the effect of RA on endothelial cell proliferation, results showed RA increased cell proliferation in a concentration-dependent manner. Am J Respir Cell Mol Biol. 2005 Dec;33(6):622-8.
THP-1 cells 10 µM 24 hours To evaluate the inhibitory effect of Palovarotene on HSV-1 replication, results showed RA inhibited HSV-1 replication in a dose-dependent manner. iScience. 2024 Jun 4;27(7):110144
Hep3B 5 µM and 10 µM 48 hours Enhanced the cytotoxicity of sorafenib Cancer Sci. 2015 May;106(5):567-75
HLF 5 µM and 10 µM 48 hours Enhanced the cytotoxicity of sorafenib Cancer Sci. 2015 May;106(5):567-75
HLE 5 µM and 10 µM 48 hours Enhanced the cytotoxicity of sorafenib Cancer Sci. 2015 May;106(5):567-75
HuH6 5 µM and 10 µM 48 hours Enhanced the cytotoxicity of sorafenib Cancer Sci. 2015 May;106(5):567-75
PLC/PRF/5 5 µM and 10 µM 48 hours Enhanced the cytotoxicity of sorafenib Cancer Sci. 2015 May;106(5):567-75
neurons 2 μM 1 week to induce neuronal differentiation Nat Biotechnol. 2011 Aug 10;29(9):824-8.
GABAergic neurons 1 μM 7 days to induce GABAergic neuron differentiation Nat Biotechnol. 2011 Aug 10;29(9):824-8.
mouse iPSCs 10 M Differentiation of mouse iPSCs into neurospheres Bioeng Transl Med. 2022 Sep 10;8(5):e10406.
femoral head chondrocytes 10 μM 3 days To investigate the effect of retinoic acid on aggrecan degradation in chondrocytes, results showed reduced aggrecan degradation products in Ndst1+/− samples upon RA treatment. Osteoarthritis Cartilage. 2020 Jul;28(7):977-987.
Neuro-2a (N2A) cells 2 μM 5 days Induced differentiation of Hb9GFP mouse stem cells into motor neurons Nat Commun. 2017 Jul 5;8:16063.
iPSC-derived motoneurons 1 µM 4-10 days Used to induce differentiation of iPSCs into motoneurons, results showed that retinoic acid at 1 µM successfully induced motoneuron differentiation. Nat Commun. 2015 Jan 12;6:5999.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Balb/c mice Pristane-induced lupus model Oral 1 mg/kg Daily administration from 3 weeks to 3 months of age (tRA pre-treatment) or from 3 to 9 months of age (tRA post-treatment) Investigate the role of tRA at different stages of lupus, finding that tRA pre-treatment exacerbates glomerulonephritis while post-treatment has immunosuppressive effects Front Immunol. 2020 Mar 20;11:408
Mouse Embryonic stem cells Culture medium 5 µM 7 days Induced differentiation of embryonic stem cells Sci Adv. 2021 Oct 29;7(44):eabk2775
Mice Osteoporosis model Gavage 70 mg/kg Once daily for 2 weeks Establish an osteoporosis model, results indicated the model was successfully established Polymers (Basel). 2018 Feb 14;10(2):185
Mice Osteoporosis model Gavage 70 mg/kg Once daily for 2 weeks To induce an osteoporosis model in mice by administering retinoic acid, the results showed that serum calcium and ALP levels in the model group were significantly increased, indicating the successful establishment of the osteoporosis model. Polymers (Basel). 2018 Feb 14;10(2):185
ICR mice UVB-induced skin damage model Oral and topical application 2 mg/kg Once daily for one week Retinoic acid as the positive control improved UVB-induced skin damage but did not significantly reduce oxidative stress and inflammation, and caused liver damage. Int J Mol Sci. 2022 Sep 16;23(18):10833

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05281965 Autism|Treatment Adherence|Ret... More >>inoic Acid|Dup15Q Syndrome Less << EARLY_PHASE1 UNKNOWN 2024-06-01 Zhejiang University, Hangzhou,... More >> Zhejiang, 310000, China|Miao pu, Hangzhou, 310009, China Less <<
NCT04417348 Melasma COMPLETED 2019-12-15 Dermatology Department. Hospit... More >>al Central "Dr. Ignacio Morones Prieto", San Luis Potosí, 78290, Mexico Less <<
NCT03999684 Adenoid Cystic Carcinoma PHASE2 COMPLETED 2020-04-15 Massachusetts General Hospital... More >> Cancer Center, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States Less <<
NCT01349556 Medication Reaction WITHDRAWN 2025-03-14 -
NCT02249767 Acne PHASE3 COMPLETED 2025-06-14 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.33mL

0.67mL

0.33mL

16.64mL

3.33mL

1.66mL

33.28mL

6.66mL

3.33mL

References

 

Historical Records

Categories